Journal Mobile Options
Table of Contents
Vol. 91, No. 1-4, 2000
Issue release date: 2000
Cytogenet Cell Genet 91:141–147 (2000)

Cloning and characterization of the breakpoint regions of a chromosome 11;18 translocation in a patient with hamartoma of the retinal pigment epithelium

Kutsche K. · Glauner E. · Knauf S. · Pomarino A. · Schmidt M. · Schröder B. · Nothwang H.G. · Schüler H.M. · Goecke T.O. · Kersten A.J. · Althaus C. · Gal A.
aInstitut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg; bMax-Planck-Institut für Molekulare Genetik, Berlin; cInstitut für Humangenetik und Anthropologie der Heinrich-Heine-Universität, Düsseldorf; and dAugenklinik der Heinrich-Heine-Universität, Düsseldorf (Germany)

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Mutations of various tumor suppressor genes, e.g., PTEN, TSC1, and TSC2, are known to be responsible for different inherited diseases presenting with multiple hamartomas, a benign tumor resembling neoplasia that results from faulty organ development. Combined hamartoma of the retinal pigment epithelium (RPE) and retina is a rare, congenital, focal malformation of the fundus. So far, no disease gene has been associated with this disorder. By molecular analysis of an apparently balanced and reciprocal translocation between the short arms of chromosomes 11 and 18, t(11;18)(p13;p11.31), in a patient with hamartoma of the RPE and retina, we selected PAC clones crossing the breakpoints on both derivative chromosomes 11 and 18. For the overlapping chromosome 11 clone, two EST clusters were identified, suggesting the existence of at least two genes in the breakpoint region. We constructed a PAC contig and showed that at least three exons of a novel gene map to the breakpoint region on chromosome 18. Based on the results of FISH analysis with the PAC clones of this contig, we suggest the occurrence of a complex rearrangement.   

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Au K-S, Hebert AA, Roach ES, Northrup H: Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J hum Genet 65:1790–1795 (1999).
  2. Bray-Ward P, Menninger J, Lieman J, Desai T, Mokady N, Banks A, Ward DC: Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CEPH YAC clones. Genomics 32:1–14 (1996).

    External Resources

  3. Carbonara C, Longa L, Grosso E, Borrone C, Garre MG, Brisigotti M, Migone N: 9q34 Loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum molec Genet 3:1829–1832 (1994).

    External Resources

  4. Carbonara C, Longa L, Grosso E, Mazzucco G, Borrone C, Garre ML, Brisigotti M, Filippi G, Scabar A, Giannotti A, Falzoni P, Monga G, Garini G, Gabrielli M, Riegler P, Danesino C, Ruggieri M, Magro G, Migone N: Apparent loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chrom Cancer 15:18–25 (1996).
  5. Caruso J, Miller KB, Pietrantonio JJ: Combined hamartoma of the retina and retinal pigment epithelium. Optom vis Sci 70:860–862 (1993).
  6. Chu G, Vollrath D, Davis RW: Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science 234:1582–1585 (1986).
  7. Decker CJ, Parker R: Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr Opin Cell Biol 7:386–392 (1995).

    External Resources

  8. Gal A, Weber B, Neri G, Serra A, Müller U, Schempp W, Page D: A 45,X male with Y-specific DNA translocated onto chromosome 15. Am J hum Genet 40:477–488 (1987).
  9. Gauwerky CE, Hoxie J, Nowell PC, Croce CM: Pre-B-cell leukemia with a t(8;14) and a t(14;18) translocation is preceded by follicular lymphoma. Oncogene 2:431–435 (1988).
  10. Giacalone J, Xu L, Lehrach H, Francke U: High-density radiation hybrid map of human chromosome 18 and contig of 18p. Genomics 37:9–18 (1996).
  11. Green AJ, Sepp T, Yates JR: Clonality of tuberous sclerosis hamartomas shown by non-random X-chromosome inactivation. Hum Genet 97:240–243 (1996).

    External Resources

  12. Green AJ, Smith M, Yates JR: Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet 6:193–196 (1994).
  13. Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ: Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chrom Cancer 13:295–298 (1995).
  14. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, Van Slegtenhorst M, Welsh CT, Kwiatkowski DJ: Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J hum Genet 59:400–406 (1996).

    External Resources

  15. Hollis GF, Gazdar AF, Bertness V, Kirsch IR: Complex translocation disrupts c-myc regulation in a human plasma cell myoma. Mol Cell Biol 8:124–129 (1988).
  16. Hosokawa Y, Suzuki R, Joh T, Maeda Y, Nakamura S, Kodera Y, Arnold A, Seto M: A small deletion in the 3′-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. Int J Cancer 76:791–796 (1998).
  17. Knudson AG: Mutations and cancer: statistical study of retinoblastoma. Proc natl Acad Sci, USA 68: 820–823 (1971).
  18. Laqua H, Wessing A: Congenital retino-pigment epithelial malformation, previously described as hamartoma. Am J Ophthalmol 87:34–42 (1979).

    External Resources

  19. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275:1943–1947 (1997).
  20. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet 16:64–67 (1997).
  21. Marsh DJ, Dahia PL, Coulon V, Zheng Z, Dorion-Bonnet F, Call KM, Little R, Lin AY, Eeles RA, Goldstein AM, Hodgson SV, Richardson AL, Robinson BG, Weber HC, Longy M, Eng C: Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutations. Genes Chrom Cancer 21: 61–69 (1998).
  22. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham Jr JM, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C, et al: PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggests a single entity with Cowden syndrome. Hum molec Genet 8:1461–1472 (1999).

    External Resources

  23. Maserati E, Waibel F, Weber B, Fraccaro M, Gal A, Pasquali F, Schempp W, Scherer G, Vaccaro R, Weissenbach J, Wolf U: A 45,X male with a Yp/18 translocation. Hum Genet 74:126–132 (1986).

    External Resources

  24. Meerabux J, Yaspo M-L, Roebroek AJ, Van de Ven WJM, Lister TA, Young BD: A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas. Cancer Res 56:448–451 (1996).
  25. Nelen MR, van Staveren WCG, Peeters EAJ, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns J-P, Sijmons RH, Woods DG, Mariman ECM, Padberg GW, Kremer H: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum molec Genet 6:1383–1387 (1997).

    External Resources

  26. Palmer ML, Carney MD, Combs JL: Combined hamartoma of the retinal pigment epithelium and retina. Retina 10:33–36 (1990).
  27. Prosser J, van Heyningen V: PAX6 mutations reviewed. Hum Mutat 11:93–108 (1998).
  28. Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JP, Santa Lucia, B, Duret L, Vuillaume M, Coiffier B, Bryon P-A, Magaud JP: Rearrangement of CCND1 (BCL1/PRAD1) 3′ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 83:3689–3696 (1994).
  29. Schwartz DC, Cantor CR: Separation of yeast chromosome-sized DNAs by pulsed field gel electrophoresis. Cell 37:67–75 (1984).
  30. Sepp T, Yares JR, Green AJ: Loss of heterozygosity in tuberous sclerosis hamartomas. J med Genet 33: 962–964 (1996).
  31. The European Chromosome 16 Tuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315 (1993).
  32. Van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Jansen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Kwiatkowski DJ, et al: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805–808 (1997).
  33. Wickens M, Anderson P, Jackson RJ: Life and death in the cytoplasm: messages from the 3′ end. Curr Opin Gene Dev 7:220–232 (1997).

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50